Docetaxel rechallenge in metastatic castration-resistant prostate cancer: A retrospective, single-center study
Purpose: To assess the efficacy and safety of docetaxel rechallenge in the salvage setting in metastatic castration-resistant prostate cancer (mCRPC) patients. Materials and Methods: Clinicopathologic data from patients treated with docetaxel rechallenge were collected from a single-center cancer re...
Main Authors: | Seonggyu Byeon, Hyera Kim, Jinchul Kim, Minsuk Kwon, Joon Young Hur, Hwang Gyun Jeon, Seong Soo Jeon, Hyun Moo Lee, Se Hoon Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Urological Association
2020-11-01
|
Series: | Investigative and Clinical Urology |
Subjects: | |
Online Access: | https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-588.pdf |
Similar Items
-
Efficacy and Prognostic Factors of Docetaxel Rechallenge on Metastatic Castration-resistant Prostate Cancer Patients
by: DUAN Liqun, et al.
Published: (2019-09-01) -
A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naïve prostate cancer
by: Sang Eun Yoon, et al.
Published: (2019-05-01) -
Docetaxel in very elderly men with metastatic castration-resistant prostate cancer
by: Hui-Li Wong, et al.
Published: (2015-06-01) -
Efficacy of Androgen Deprivation Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel-Based Chemotherapy
by: Kyungchan Min, et al.
Published: (2020-04-01) -
A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer
by: Eric Zhuang, et al.
Published: (2021-11-01)